Triangulation to make decisions about what are modifiable risk factors and the new risk factors
Abstract Background The 2020 Lancet Commission on dementia prevention, intervention and care estimated that up to 40% of dementia cases could be prevented by tackling 12 potentially modifiable risk factors, namely less education, hearing loss, hypertension, physical inactivity, diabetes, social isolation, excessive alcohol consumption, air pollution, smoking, obesity, traumatic brain injury, depression. As more evidence on risk factors emerges, the Lancet standing commission on dementia met to update evidence on established dementia risk factors and to consider the evidence for other risk factors. Method We used a lifecourse approach to understand how to reduce risk or prevent dementia, as many risks operate at different timepoints in the lifespan. We considered evidence for when in the lifecourse a risk factor was relevant to development of dementia as well as the size of the effect and strength of the evidence. Our interdisciplinary, international, multicultural group of experts adopted a triangulation framework, prioritising systematic reviews and meta‐analyses, performing new meta‐analyses where needed and debated and agreed on the best available evidence and its consistency. We considered whether there was evidence of disparities in impact of risk factors based on demographic characteristics, particularly ethnicity and socioeconomic status. Result Evidence for two new risk factors was considered strong enough to include this in our lifecourse model. We will present evidence for incorporation of these risk factors, including strength of evidence and potential mechanisms. We will also discuss risk factors for which evidence was not strong enough. Conclusion As more evidence about risk factors emerges we can increase our understanding of how dementia develops and how to potentially prevent it. Understanding the landscape of dementia prevention research is also helpful to appreciate where further evidence is needed and what form of evidence would be most helpful in advancing our understanding.
Authors
- Laura N. Gitlin (ORCID: https://orcid.org/0000-0003-2869-473X)
- Suvarna Alladi (ORCID: https://orcid.org/0000-0002-0372-9572)
- Noeline Nakasujja (ORCID: https://orcid.org/0000-0002-8163-4376)
- Kenneth J. Rockwood (ORCID: https://orcid.org/0000-0002-6674-995X)
- Geir Selbæk (ORCID: https://orcid.org/0000-0001-6511-8219)
- Sebastian Walsh (ORCID: https://orcid.org/0000-0001-8894-5006)
- Nick C. Fox (ORCID: https://orcid.org/0000-0002-6660-657X)
- Quincy M. Samus (ORCID: https://orcid.org/0000-0001-8218-7769)
- Alistair Burns (ORCID: https://orcid.org/0000-0002-9837-0645)
- Mika Kivimaki B (ORCID: https://orcid.org/0000-0002-4699-5627)
- Sube Banerjee (ORCID: https://orcid.org/0000-0002-8083-7649)
- Eric B. Larson (ORCID: https://orcid.org/0000-0003-4782-5360)
- Robert Howard (ORCID: https://orcid.org/0000-0002-3071-2338)
- Cleusa P. Ferri (ORCID: https://orcid.org/0000-0002-1815-7685)
- Lon S. Schneider (ORCID: https://orcid.org/0000-0002-4636-6150)
- Archana Singh‐Manoux (ORCID: https://orcid.org/0000-0002-1244-5037)
- Gill Livingston (ORCID: https://orcid.org/0000-0001-6741-5516)
- Jonathan Huntley (ORCID: https://orcid.org/0000-0001-6304-6231)
- Helen C. Kales (ORCID: https://orcid.org/0000-0002-2032-370X)
- Kathy Liu (ORCID: https://orcid.org/0000-0002-7482-2758)
- Andrew Sommerlad (ORCID: https://orcid.org/0000-0002-8895-7055)
- Carol Brayne (ORCID: https://orcid.org/0000-0001-5307-663X)
- Naaheed Mukadam (ORCID: https://orcid.org/0000-0001-8635-9521)
- Sergi Costafreda Gonzalez
- Yao Yao (ORCID: https://orcid.org/0000-0002-6723-6152)
- Kokoro Shirai (ORCID: https://orcid.org/0000-0002-7014-817X)
- David Ames
Institutions
- Dalhousie University (CA)
- University of Nottingham (GB)
- Johns Hopkins University (US)
- University of Washington (US)
- Peking University (CN)
- University of Exeter (GB)
- University of Cambridge (GB)
- Keck Hospital of USC (US)
- Sykehuset i Vestfold (NO)
- University of Manchester (GB)
- National Ageing Research Institute (AU)
- Cambridge University Health Partners (GB)
- University College London (GB)
- National Institute of Mental Health and Neurosciences (IN)
- Makerere University (UG)
- Drexel University (US)
- University of California, Davis (US)
- Universidade Federal de São Paulo (BR)
- The University of Osaka (JP)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.085067
- Primary Topic
- Global Public Health Policies and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00